Dieses Bild zeigt  Martin Weiss

Herr Jun.-Prof. Dr. med.

Martin Weiss

Clinician Scientist C2
Eberhard Karls Universität Tübingen
Universitätsklinikum, Frauenklinik
[Foto: Martin Weiss, Frauenklinik]

Kontakt

+49 7071 29 82211 (Pforte)

Calwerstr. 7
72076 Tübingen
Deutschland

Publikationsverzeichnis

Originalartikel
(*equally contributed)

2020                26                    Feuerer N, Morschl J, Daum R, Weiss M, Hinderer S, Schenke-Layland K, Shipp C.
Macrophage retrieval from 3D biomaterials: a detailed comparison of common dissociation methods. Submitted

                        25                    Andress J, Krämer B, Schönfisch B, Brucker S, Kommoss S, Pasternak J, Walter C, Weiss M, Hartkopf A, Steinmacher S. Fertility preserving Management of early Endometrial Cancer in a patient cohort at the Department of Women´s Health at the University of Tübingen. BJOG: An International Journal of Obstetrics & Gynaecology Submitted

                        24                    Haralambiev L, Bandyopadhyay A, Suchy B, Weiss M, Kramer A, Bekeschus S, Ekkernkamp A, Mustea A, Kaderali L, Stope MB. Determination of immediate vs. kinetic growth retardation in physically plasma-treated cells by experimental and modelling data. Anticancer research 2020, 40

                        23                    Feil L*, Koch A*, Utz R, Ackermann M, Barz J, Stope M, Krämer B, Wallwiener D, Brucker SY, Weiss M. Cancer-Selective Treatment of Cancerous and Non-Cancerous Human Cervical Cell Models by a Non-Thermally Operated Electrosurgical Argon Plasma Device. Cancers 2020, 12, 1037. https://doi.org/10.3390/cancers12041037
Impact: 6,13

                        22                    Daum R, Visser D, Wild C, Kutuzova L, Schneider M, Lorenz G, Weiss M, Hinderer S, Stock UA, Seifert M, Schenke-Layland K. Fibronectin adsorption on electrospun synthetic vascular grafts attracts endothelial progenitor cells and promotes endothelialization in dynamic in vitro culture. Cells 2020, 9(3), 778; doi:10.3390/cells9030778

                        21                    Wenzel T, Carvajal Berrio DA, Reisenauer C, Layland S, Koch A, Wallwiener D, Brucker SY, Schenke-Layland K, Brauchle EM, Weiss M. Trans-Mucosal Efficacy of Non-Thermal Plasma Treatment on Cervical Cancer Tissue and Human Cervix Uteri by a Next Generation Electrosurgical Argon Plasma Device. Cancers 2020, 12, 267; doi:10.3390/cancers12020267
Impact: 6,13 (2019)

2019                20                    Wenzel T, Carvajal Berrio D, Daum R, Reisenauer C, Weltmann KD, Wallwiener D, Brucker S, Schenke-Layland K, Brauchle EM*, Weiss M*. Molecular Effects and Tissue Penetration Depth of Physical Plasma in Human Mucosa Analyzed by Contact- and Marker-Independent Raman Microspectroscopy. ACS Applied Materials & Interfaces 2019 Nov 20;11(46):42885-42895. doi: 10.1021/acsami.9b13221
IF: 8,758

                        19                    Weiss M, Barz J, Ackermann M, Utz R, Ghoul A, Weltmann KD, Stope MB, Wallwiener D, Schenke-Layland K, Oehr C, Brucker S, Loskill P. Dose-Dependent Tissue-Level Characterization of a Medical Atmospheric Pressure Argon Plasma Jet. ACS Applied Materials & Interfaces. 2019 Jun 5;11(22):19841-19853. Doi: 10.1021/acsami.9b04803.
IF: 8,758

                        18                                Weiss M*, Stope MB*, Popp SL, Joffroy C, Wallwiener D, Brucker SY, Mustea A, Buck MB, Knabbe C. The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro. Eur. J. Gynaecol. Oncol. 2019 doi: 10.12892/ejgo4282.2019.
IF: 0,617 (2017)

                        17                    Hoffmann SM, Kappel D, Fech A, Enderle MD, Weiss M, Hahn M, Brucker SY, Kraemer B. Thermal effects of a novel electrosurgical device for fucused preparation in breast surgery tested in a specified porcine tissue ex vivo breast model using infrared measurement. Arch Gynecol Obstet (2019) 299:835-840 doi: 10.1007/s00404-018-5024-x Ahead of print
IF: 1,937 (2017)

2018                16                    Weiss M, Utz R, Ackermann M, Taran FA, Krämer B, Hahn M, Wallwiener D, Brucker S, Haupt M, Barz J, Oehr C. Characterization of a non‐thermally operated electrosurgical argon plasma source by electron spin resonance spectroscopy. Plasma Proc. Polym. 2018 10.1002/ppap.201800150
IF: 3,173

                        15                    Simoes E, Graf J, Sokolov AN, Grischke EM, Hartkopf AD, Hahn M, Weiss M, Abele H, Seeger H, Brucker SY. Pregnancy-associated breast cancer: maternal breast cancer survival over 10 years and obstetrical outcome at a university centre of women's health. Arch Gynecol Obstet. 2018. doi: 10.1007/s00404-018-4822-5. [Epub ahead of print]
IF: 2,236 (2017)

                        14                    Weiss M*, Koensgen D*, Assmann K, Brucker SY, Wallwiener D, Stope MB, Mustea A. Characterization and Management of Borderline Ovarian Tumors – Results of a Retrospective, Single-center Study of Patients Treated at the Department of Gynecology and Obstetrics of the University Medicine Greifswald. Anticancer res. 2018; 38: 1539-1545.
IF: 1,865 (2017)

2017                13                    Weiss M*, Stope MB*, Popp SL, Joffroy C, Mustea A, Buck MB, Knabbe C. Y-box binding protein-1 enhances oncogenic transforming growth factor β signaling in breast cancer cells via triggering phospho-activation of Smad2. Anticancer res. 2017; 37:6745-6748.
IF: 1,865

                        12                    Koensgen D, Besic I, Gümbel D, Kaul A, Weiss M, Diesing K, Kramer A, Bekeschuss S, Mustea A, Stope MB. Cold Atmospheric Plasma (CAP) and CAP-Stimulated Cell Culture Media Suppress Ovarian Cancer Cell Growth – A Putative Treatment Option in Ovarian Cancer Therapy. Anticancer res. 2017; 37: 6739-6744.
IF: 1,865

11                               Koensgen D, Sehouli J, Belau A, Weiss M, Stope MB, Großkopf V,  Eichbaum M, Lewdon P, Lichtenegger W, Zygmunt M, Köhler G, Mustea A. Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an open prospective, multicenter phase 2 study of the North-Eastern Society of Gynaecological Oncology. Int J Gynecol Cancer. 2017, 27 :500-506.
IF: 2,192

2016               10                     Gümbel D, Gelbrich N, Weiss M, Daeschlein G, Sckell A, Ender SA, Kramer A, Burchardt M, Ekkernkamp A, Stope MB. New Treatment Options for Osteosarcoma – Inactivation of Osteosarcoma Cells by Cold Atmospheric Plasma. Anticancer Research 2016, 36:5915-5922.
IF: 1,937

9                      Weiss M, Ahrend H, Grossebrummel H, Ziegler P, Brandenburg LO, Walther R, Zimmermann U, Burchardt M, Stope MB. Cytochrome P450 17A1 Inhibitor Abiraterone Acetate Counteracts the Heat Shock Protein 27's Cell Survival Properties in Prostate Cancer Cells. Urol Int. 2016;97(1):112-7.
IF: 1,611

8                      Stope MB, Wiegank L, Weiss M, Diesing K, Koensgen D, Burchardt M, Zygmunt M, Mustea A. Drug-induced modulation of heat shock protein 27 in an ovarian cancer cell model. Anticancer Res. 2016 36(7):3321-7.
IF: 1,937

7                      Robert Mandelkow, Daniela Brünnert, Weiss M, Dominique Koensgen, Martin Burchardt, Marek Zygmunt, Alexander Mustea, Matthias B. Stope. Lysophosphatidic acid receptor isoforms expression in prostate cancer cells is differentially regulated by the CYP17A1 inhibitor abiraterone and depends on the androgen receptor. Adv Mod Oncol Res 2016  2(1).

6                      Großebrummel H, Peter T, Mandelkow R, Weiss M, Muzzio D, Zimmermann U, Walther R, Jensen F, Knabbe C, Zygmunt M, Burchardt M, Stope MB. Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from the androgen receptor. Int J Oncol. 2016 Feb;48(2):793-800.
IF: 3,079

2015               5                      Weiss M, Gümbel D, Gelbrich N, Brandenburg LO, Mandelkow R, Zimmermann U, Ziegler P, Burchardt M, Stope MB. Inhibition of Cell Growth of the Prostate Cancer Cell Model LNCaP by Cold Atmospheric Plasma. In Vivo. 2015 09-10;29(5):611-616.
IF: 0,832

4                      Weiss M, Gümbel D, Hanschmann EM, Mandelkow R, Gelbrich N, Zimmermann U, Walther R, Ekkernkamp A, Sckell A, Kramer A, Burchardt M, Lillig CH, Stope MB. Cold Atmospheric Plasma Treatment Induces Anti-Proliferative Effects in Prostate Cancer Cells by Redox and Apoptotic Signaling Pathways. PLoS One. 2015 10:e0130350.
IF: 3,057

2014               3                      Stope MB*, Weiss M*, Preuss M, Streitbörger A, Ritter CA, Zimmermann U, Walther R, Burchardt M. Immediate and transient phosphorylation of the heat shock protein 27 initiates chemoresistance in prostate cancer cells. Oncol Rep. 2014 32:2380-6
IF: 2,301

2                      Stope MB, Stender C, Schubert T, Peters S, Weiss M, Ziegler P, Zimmermann U, Walther R, Burchardt M. Heat-shock Protein HSPB1 Attenuates MicroRNA miR-1 Expression Thereby Restoring Oncogenic Pathways in Prostate Cancer Cells. Anticancer Res. 2014 34:3475-80
IF: 1,826

2013               1                      Stope MB, Bradl J, Peters S, Streitbörger A, Weiss M, Zimmermann U, Walther R, Lillig CH, Burchardt M. Shortened isoforms of the androgen receptor are regulated by the cytoprotective heat-shock protein HSPB1 and the tumor-suppressive microRNA miR-1 in prostate cancer cells. Anticancer Res. 2013 33:4921-6
IF: 1,826

Übersichtsartikel

2019                4                      Grube M, Neis F, Brucker SY, Kommoss S, Andress J, Weiss M, Hoffmann S, Taran FA, Krämer B. Uterine Fibroids - Current Trends and Strategies. Surgical Technology International 2019 34

2018                3                      Nawroth J, Rogal J, Weiss M, Brucker SY, Loskill P. Organ-on-a-Chip Systems for Women’s Health Applications. Adv Healthc Mater 2018; 7.
IF: 5,609 (2017)

2017                2                      Weiss M, Daeschlein G, Kramer A, Burchardt M, Brucker S, Wallwiener D, Stope MB. Virucide properties of cold atmospheric plasma for future clinical applications. J Med Virol 2017 89:952-959
IF: 1,988

2016                1                      Weiss M, Brandenburg LO, Burchardt M, Stope MB. MicroRNA-1 properties in cancer regulatory networks and tumor biology. Crit Rev Oncol Hematol. 2016 104:71-7.
IF: 6,296

Lehr- und Handbuchbeiträge, Monographien

 

2020                22                    Non-invasive physical plasma (NIPP) treatment of low- and high-grade cervical intraepithelial neoplasia: a non-invasive and anesthesia-independent treatment procedure evaluated in a prospective, monocentric clinical trial. Henes M, Neis F, Enderle M, Bösmüller H, Wallwiener D, Brucker S, Weiss M. ICPM Chorea 2020

                        21                    Non-invasive-physical-plasma treatment of low- and high-grade cervical intraepithelial neoplasia: a non-invasive and anaesthesia-independent treatment procedure evaluated in a prospective, monocentric clinical trial. Henes M, Bösmüller H, Neis F, Wallwiener D, Brucker S, Weiss M. DGGG München 2020

                        20                    Human immunocompetent Choroid-on-chip: a promising tool for studying ocular side effects of biological drugs. Cipriano M, Probst C, Schlünder K, Linke K, Laistner L, Weiss M, Schneider A, Kustermann S, Loskill P. Eurotox 2020 and WC11 2020

                        19                    Development of a microphysiological platform for the integration of primary human cervical tissue. Kromidas E, Zimmermann C, Weiss M, Loskill P. EUROoC 2020.

2019                18                    Human Immunocompetent Choroid-on-a-chip: a key tool for studying ocular side effects of biological drugs. Madalena Cipriano, Christopher Probst, Katharina Schlünder, Kirstin Linke, Martin Weiss, Anneliese Schneider, Annie Moisa, Stefan Kustermann, Peter Loskill. 1st annual conference of the European Organ-on-Chip Society, 2.-3. July 2019, Graz.

                        17                    Eva Brauchle, Tara Beyer, Daniel Carvajal Berrio, Andrea Hornberger, Sara Y. Brucker, Katharina K. Rall, Martin Weiss and Katja Schenke-Layland. Characterization of endometriosis and comparison to endometrial cancer using Raman microspectroscopy. WITec Symposium 2019

                        16                    Martin Weiss, Ruben Daum, Svenja Hinderer, Eva Brauchle, Diethelm Wallwiener, Sara Brucker, Katja Schenke-Layland. Cold atmospheric plasma for potential in vivo applications: Raman microsprectrometry determined effects on cervical cancer cells. European Journal of Obstetrics and Gynecology and Reproductive Biology, 2019 Vol. 234, e162–e163

                        15                    Andrina Kölle, Michael Ackermann, Raphael Utz, Michael Haupt, Jakob Barz, Christian Oehr, Andrei Taran, Diethelm Wallwiener, Sara Brucker, Martin Weiss. Ex vivo characterization of thermal argon plasma sources for potential cold atmospheric plasma application in medicine. European Journal of Obstetrics and Gynecology and Reproductive Biology, 2019 Vol. 234, e83–e84

                        14                               Lukas Feil, André Koch, Sara Brucker, Diethelm Wallwiener, Martin Weiss. Inhibition of cervical cancer cell growth by non-thermal atmospheric plasma application utilizing a thermal argon plasma source. European Journal of Obstetrics and Gynecology and Reproductive Biology, 2019 Vol. 234, e131

2018                13                    Stope M, Koensgen D, Wulff C, Besic I, Gümbel D, Kaul A, Weiss M,  Diesing K, Kramer A, Mustea A, Bekeschus S. Cold Atmospheric Plasma Suppresses Ovarian Cancer Cell Activity With Concurrent Secretion Of Heat Shock Protein 27 Affecting Monocyte Fate. Clinical Plasma Medicine, Supplement, 2018 9: 25-26.

                        12                    Stope MB, Koensgen D, Wulff C, Besic I, Gümbel D, Kaul A, Weiss M, Diesing K, Kramer A, Mustea A, Bekeschus S. Cold Atmospheric Plasma Suppresses Ovarian Cancer Cell Activity With Concurrent Secretion Of Heat Shock Protein 27 Affecting Monocyte Fate. Clinical Plasma Medicine 9 (2018) 2–48  

2017                11                    Weiss M. Kaltplasma zur Behandlung von Virus-assoziierten Erkrankungen und Infektionen? In: Daeschlein G., Plasma-Medizin - Neue Wege der Haut-, Wund- und Krebsbehandlung in Theorie und Praxis, UNI-MED Science, Bremen, 1. Auflage 2017, S. 97.

                        10                                Martin Weiss, Svenja Hinderer, Ruben Daum, Eva Brauchle, Christian Oehr, Diethelm Wallwiener, Sara Y. Brucker, Katja Schenke-Layland. The impact of cold atmospheric plasma on cervical cancer cells for potential in vivo applications. Abstract, FOG Kongress der Arbeitsgemeinschaft Gynäkologische Endoskopie, Berlin 21.-23.09.2017

2016                9                                 Weiss M, Engler T, Wißlicen K, Rava L, Walter CB, Hahn M, Taran FA, Wallwiener D, Grischke EM, Brucker SY, Hartkopf AD. Management of breast cancer in pregnant women—experiences from a large university breast center. Senol Z Mammadiagn Ther 2016 13:144. https ://doi.org/10.1055/s-0036-15834 66

                                               Martin Weiss, Matthias B. Stope, Gerd Klinkmann, Dominique Koensgen, Sara Brucker, Diethelm Wallwiener, Martin Burchardt, Alexander Mustea. Induction and secretion of cytoprotective heat shock protein 27 in ovarian cancer cells. Abstract und Posterbeitrag, Deutscher Krebskongress, Berlin, 24.-27.02.2016

8                                  Weiss M, Engler T, Wißlicen K, Rava L, Walter C, Hahn M, Taran FA, Wallwiener D, Grischke EM, Brucker SY, Hartkopf AD. Management of breast cancer in pregnant women - experiences from a large university breast center. Posterbeitrag anlässlich 36. Jahrestagung der Deutschen Gesellschaft für Senologie, Dresden 26.-28.05.2016.

7                                  Gümbel D, Gelbrich N, Weiss M, Napp M, Lange L, Burchardt M, Ekkernkamp A, Stope MB. Der Einsatz von kaltem physikalischen Plasma (Cold atmospheric Plasma) bei chirurgischen Operationen. 133. Kongress der Deutschen Gesellschaft für Chirurgie, Berlin, 26.-29.04.2016.

2015                6                                  Weiss M, Gümbel D, Hanschmann EM, Mandelkow R, Zimmermann U, Walther R, Ekkernkamp A, Sckell A, Burchardt M, Kramer A, Lillig CH, Stope MB. Giving a face to cold atmospheric plasma – the impact on prostate cancer and the role of redox signaling. Urologe 2015 54:110

Ausgezeichnet mit dem AUF-Forschungspreis der Deutschen Gesellschaft für Urologie, anlässlich des 6. Symposiums Urologischer Forschung 15.11.2014, Homburg/Saar.

2014                5                                  Stope MB, Weiss M, Stender C, Preuß M, Peters S, Schubert T, Streitbörger A, Zimmermann U, Walther R, Burchardt M. Chemoresistance in prostate cancer is initiated by phosphorylation of the heat shock protein 27 and subsequent suppression of the tumor suppressor microRNA 1. Anlässlich 66. Kongress der DGU - Düsseldorf  01.-04.10.2014

4                                  Stope MB, Gümbel D, Weiss M, Sckell A, Zimmermann U, Walther R, Lillig CH, Ekkernkamp A, Burchardt M. Physikalisches Niedertemperatur-Plasma hemmt das Wachstum maligner Prostatazellen – Ein neues Schwert für die Chirurgie der Zukunft? Anlässlich 8. Nordkongress der VNU - Cottbus - 12.-14.06.2014

3                                  Rottach M, Peter T, Mandelkow R, Weiss M, Walther R, Burchardt M, Stope MB. Cytostatic drug WIST-C overcomes docetaxel induced resistance. Urologe 2014 53:103–127

2013                2                                 Weiss M, Schubert T, Peters S, Rauschenberger L, Staar D, Rönnau C, Walther R, Burchardt M, Stope MB. Heat shock protein HSP27 confers resistance to Docetaxel in prostate cancer cells. Urologe 2013 52:99–127 

                        1                      Weiss M. Steuerung der Docetaxelresistenz von Prostatakarzinomzellen durch Proteinphosphorylierungen von Hitzeschockprotein 27. Ernst-Moritz-Arndt-Universität Greifswald, 2013

Kommentare

2020                                                   Recker F, Riedel F., Stope M., Mustea A, Weiss M, Jennebach J. Kerncurriculum des Medizinstudium – Der Masterplan Medizinstudium 2020 und die Implementierung des Nationalen Kompetenzbasierten Lernzielkatalogs Medizin – Chancen und Herausforderungen für die Gynäkologie und Geburtshilfe. Geburtshilfe Frauenheilkd 2020; 80(06): 570-573

                                               Winder F, Favero M, Breuer G, Fössleitner P, Friemann M, Weiss M. Unter einem „D-A-CH“. Gemeinsame Initiative der Jungen Foren Deutschland, Schweiz und Österreich. FRAUENARZT 2020 61 (05) 426

                                               Recker F, Schulmeyer C, Becker L, Weiss M. PJ-Wahlfach in der Corona-Krise. FRAUENARZT 2020 61 (04) 311

                                               Puppe J, Seelbach-Göbel B, Scharl A, Albring C, Weiss M, Hepp V, Gabriel L, Mallmann P, Aydeniz B, Blohmer JU, Solbach C, Wallwiener M, Fehm T. Gynäko-onkologische Weiterbildung: eine bundesweite Bestandsaufnahme. FRAUENARZT 2020 61 (03) 226

 

 

2019                9                      Weiss M, Vera Hepp. Europäische Verständigung – Four Countries Meeting in München. FRAUENARZT 2019 60 (10) 697

                        8                      Friemann M, Weiss M. Das Interview zum PACT-Curriculum - Auf dem Weg zu einer standardisierten europäischen Weiterbildung. FRAUENARZT 2019 60 (9) 614 

                        7                      Weiss M, Winterholler F. Das Junge Forum der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe stellt sich vor. Gynäkologe 2019 https://doi.org/10.1007/s00129-019-4406-x

                        6                      Weiss M, Winterholler F. Das Junge Forum der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe stellt sich vor. Forum (), 1-3 doi: 10.1007/s12312-018-0553-6

2018                5                      Riedel F, Weiss M, Stope MB. Neue Möglichkeiten in der gynäkologischen Onkologie – kaltes physikalisches Plasma. Gynäkologe https://doi.org/10.1007/s00129-018-4361-y

                        4                      Simoes E, Graf J, Sokolov AN, Grischke EM, Hartkopf AD, Hahn M, Weiss M, Abele H, Seeger H, Brucker SY. 10-Jahres-Überlebensrate und Geburtsoutcomes bei Schwangerschafts-assoziiertem Brustkrebs. Senologie - Zeitschrift für Mammadiagnostik und -therapie 2018 15(02). DOI: 10.1055/s-0038-1651803.

                        3                      Weiss M, Stope MB Physical plasma - a new treatment option in gynecological oncology. Arch Gyn Obst. 2018 Accepted

2014                2                      Stope MB, Weiss M, Burchardt M Evaluation of new generation drugs for advanced prostate cancer treatment necessitates further understanding of the underlying molecular modes of action. J Urol Res 2014 1, 1011

                        1                      Weiss M, Burchardt M, Stope MB. Master of puppets in prostate cancer: heat shock protein 27 is pulling androgen receptor’s strings. Can Cell Microenviron. 2014 1: e287

 

Interviews

2020                                       Gynäkolog:innen begleiten ihre Patientinnen oft jahrzehntelang. https://arztundkarriere.com/allgemein/weiterbildung-gynaekologie-geburtshilfe/

Junge Ärzte der DGGG: Unser Fach ist das schönste! Frauenheilkunde und Geburtshilfe, 07.10.2020
Die Deutsche Gesellschaft für Gynäkologie und Geburtshilfe betritt dieser Tage Neuland – wenn sie ihren 63. Kongress erstmals als Hybrid-Veranstaltung abhält. Es wird sowohl Präsenzveranstaltungen als auch Online-Sitzungen geben. Gerade die jüngeren Kolleginnen und Kollegen stehen dem Neuen aufgeschlossen gegenüber. Im esanum-Podcast fragen wir dazu zwei Sprecher des Jungen Forums in der DGGG: Dr. Nora Kießling vom Vivantes Klinikum Berlin Neukölln und Prof. Dr. Martin Weiß von der Universitätsfrauenklinik Tübingen.
https://www.esanum.de/conferences/dggg-der-gynaekologiekongress/feeds/today/posts

 

 

Research Experience

  • Since 07/2019 Assistant Professor for Molecular Gynecology Dept. of Women’s Health, Research Institute for Women’s Health Faculty of Medicine, Eberhard Karls University Tübingen, Germany
  • 05/2017-06/2019 Associate Postdoctoral Researcher Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart
  • Since 01/2016 Clinician scientist and MD for Obstetrics and Gynecology, Dept. of Women’s Health, Research Institute for Women’s Health Faculty of Medicine, Eberhard Karls University Tübingen, Germany

Higher Education

  • 10/2009 Doctoral Thesis: “Control of docetaxel resistance in prostate cancer cells by protein phosphorylation of the heat shock protein 27”, Grade: summa cum laude
  • 10/2009–11/2015 Medschool Human medicine, University of Greifswald, Germany, Grade: 1,8
  • 03/2009–09/2009 Diploma student, University of Innsbruck, Austria, Majors: Biology

Awards

  • Dissertation prize, Society of Northern German Urologists (VNU), 04/2013
  • Platform presentation award, German Society of Urology, Homburg/Saar, 11/2014
  • IAAM Scientist Award, International Association of Advanced Materials, Sweden, 07/2020

Scientific Activities and Memberships

  • Elected speaker for residents, German Society for Gynecology and Obstetrics (DGGG), since 10/2018
  • Elected Executive Board Member, German Society for Gynecology and Obstetrics (DGGG), since 10/2018
  • Board Member, “Standards of Care”, European Board and Colege of Obstetrics and Gynecology (EBCOG)
  • Member, Working group for Gynecological Endoscopy (AGE), professional Association of Gynecologists Germany (BVF), German Socienty for Gynecology and Obstetrics, German Society for Senology
  • Board Member, Taskforce Technology Transfer, Medical Faculty of the Eberhard Karls University Tübingen, since 01/2020
  • Board Member, Taskforce Informatics Technology Research & Development (IT-A-R&D), Medical Faculty of the Eberhard Karls University Tübingen, since 01/2019
Zum Seitenanfang